{"id":3117,"date":"2026-02-05T09:30:00","date_gmt":"2026-02-05T14:30:00","guid":{"rendered":"https:\/\/p175905stg.bridgespecialtygroup.com\/?p=3117"},"modified":"2026-02-05T15:58:20","modified_gmt":"2026-02-05T20:58:20","slug":"staying-ahead-of-life-sciences-risk","status":"publish","type":"post","link":"https:\/\/p175905stg.bridgespecialtygroup.com\/eu\/news\/staying-ahead-of-life-sciences-risk\/","title":{"rendered":"Staying ahead of Life Sciences risk"},"content":{"rendered":"\n
\n
Check out our recent successes!<\/a><\/div>\n<\/div>\n\n\n\n

<\/p>\n\n\n\n

Bridge Specialty Group holds market recognition that enables us to connect retail partners with tailored insurance solutions, and we do that through our specific practice groups including Property, Casualty, Environmental, Executive Risk, Farm & Ranch, Healthcare, Life Sciences, Personal Lines, Public Entity, Transportation and Workers\u2019 Compensation.<\/p>\n\n\n\n

As we continue to expand our products and capabilities through these practice groups, we\u2019re excited to highlight our Life Sciences Practice Group, led by Illana Goldfinger.<\/p>\n\n\n\n

Life sciences is one of the most complex\u2014and fascinating\u2014sectors in the insurance industry. It\u2019s an arena defined by rapid innovation, evolving risk, global collaboration and deeply human outcomes. Our life sciences specialists understand the complex risks facing companies involved in clinical trials, biotechnology, medical product manufacturing and related disciplines. Everything from early-stage research and development through commercialization.<\/p>\n\n\n\n

Illana Goldfinger\u2019s experience and vision guides our Life Sciences Practice Group<\/h4>\n\n\n\n

Illana Goldfinger\u2019s career has been shaped by deep expertise, relentless curiosity and a genuine passion for educating others about this interesting sector.<\/p>\n\n\n\n

She brings decades of hands\u2011on experience, specialized knowledge and an unmatched global perspective to this role, making her a trusted resource for brokers, carriers and clients alike.<\/p>\n\n\n\n

Her path into insurance was anything but traditional\u2014and that\u2019s part of what makes her such a compelling leader. She entered the industry through an administrative role at International Program Managers, where she quickly became the company\u2019s in\u2011house technology expert before moving into account management and eventually life sciences specialization. Over more than 20 years\u2014and through multiple acquisitions\u2014Illana has continually evolved her role while remaining focused on solving complex coverage challenges.<\/p>\n\n\n\n

\u201cThe fun part of insurance is getting creative,\u201d she said. \u201cWhen coverage isn\u2019t straightforward, that\u2019s when we dig in and look for a solution.\u201d<\/p>\n\n\n\n

That problem\u2011solving mindset in the life sciences market continues to define her approach today.<\/p>\n\n\n\n

A strong global perspective<\/h4>\n\n\n\n

One of Illana\u2019s most distinctive strengths is her long\u2011standing work with foreign life sciences companies and international brokers. From early in her career, she helped build and maintain relationships across Europe, Israel and beyond\u2014connections that still drive business today.<\/p>\n\n\n\n

She sees enormous strategic value in Bridge Specialty Group\u2019s global footprint and believes it creates a powerful competitive advantage:<\/p>\n\n\n\n

\u201cWhat really sets us apart is our ability to be the go\u2011to resource for foreign life sciences companies entering the U.S. When a company has a U.S. entity, they come to me. Because we already have offices overseas, we can collaborate seamlessly with those teams and identify the right brokers to connect with. That global reach lets us support clients in a way many others simply can\u2019t.\u201d<\/p>\n\n\n\n

This international lens allows Illana to navigate differences in regulatory frameworks, coverage availability and underwriting comfort\u2014particularly around U.S. exposures like EPL, clinical trials and product liability that often can\u2019t be placed in a company\u2019s home country.<\/p>\n\n\n\n

A passion for education and collaboration<\/h4>\n\n\n\n

Illana\u2019s experience serves the strength of the Life Sciences practice group, and if there\u2019s one theme that runs consistently through her work, it\u2019s her dedication to education. She openly acknowledges that life sciences can feel unfamiliar\u2014or even intimidating\u2014for those not immersed in it every day, and she sees education as the key to elevating the entire distribution channel. She frequently co\u2011brokers accounts and joins client meetings so retail partners can confidently guide their clients, even when risks are nuanced or highly specialized. Illana shared:<\/p>\n\n\n\n

\u201cI\u2019m deeply passionate about education, especially when it comes to life sciences. Helping others understand this space is something I genuinely enjoy,\u201d Illana shared. \u201cI see my role as an extension of the broker\u2019s team\u2014providing the expertise that helps them speak confidently and knowledgeably with their clients.\u201d<\/p>\n\n\n\n

Identifying life sciences trends in a rapidly evolving sector<\/strong><\/h4>\n\n\n\n

Life sciences is anything but static\u2014and Illana thrives on staying ahead of what\u2019s next. She closely tracks emerging therapies, regulatory shifts, litigation patterns and market responses to understand how risk is evolving.<\/p>\n\n\n\n

According to Illana, 2026 is shaping up to be a defining year for risk management and insurance in the life sciences sector. Innovation is accelerating, and so are the exposures that insurers and insureds must navigate.<\/p>\n\n\n\n

Some key areas to watch in 2026 are:<\/p>\n\n\n\n